ArticleBMC women's health2026
Family planning service quality and contraceptive discontinuation among short-acting contraceptive users in Indonesia: a survival analysis of the 2017 Indonesia demographic health survey.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundContraceptive discontinuation rates in Indonesia are higher among short-acting contraceptive users. The quality of family planning services was suspected to be the cause. The Indonesian Demographic Health Survey (IDHS) assesses family planning, discontinuation rates, and factors related to family planning. This study aimed to analyze short-acting contraceptive discontinuation and the quality of family planning services using The IDHS 2017 data.
methodsThis research analyzes data from the 2017 IDHS of women aged 15-49 years who had been using contraception in the last five years preceding the survey. Data on contraceptive discontinuation rates, reasons for discontinuation, contraceptive methods, sources of family planning services, caregivers, contraceptive decision makers, and contraceptive payment methods were extracted from the survey. Family planning service quality was assessed through the method information index (MII) from the 2017 IDHS. Survival analysis and the Cox proportional hazard model were used to analyze family planning service quality and contraceptive discontinuation.
resultsThe overall contraceptive discontinuation rate for short-acting contraceptive method (pills, injectable) in Indonesia was 43.6%. The complete MII or informed choice rate was 30%. Episodes with complete MII discontinue earlier than those incomplete. Approximately 60% of the discontinuations involved the use of injectables, but pill users discontinued earlier. The main reason for discontinuation is side effects. The Cox proportional hazard model revealed several variables that were significantly associated: complete MII (Hazard Ratio or HR 1.1), the use of a pill (HR 2.9) or an injectable contraceptive (HR 2.8), switching to other methods (HR 7.5), switching to long-acting reversible contraception (LARC) (HR 6,9), the use of other service sources (HR 2.0), age ≤ 29 years (HR 1.4), and age 30-34 years (HR 1.2).
conclusionsThe number of contraceptive discontinuation episodes in Indonesia was quite high, with few informed choices, although those with informed choices discontinued earlier. It is possible that those with informed choice acknowledge the contraceptive side effects and then choose to discontinue. Considering those who discontinue and switch to other methods, it is crucial to improve the quality of counseling with the aim of making optimal informed choices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.